Geneos Wealth Management Inc. Nevro Corp Transaction History

Geneos Wealth Management Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 08, 2021	SELL	$141.6 - $179.06 $5,805 - $7,341	-41 Closed	0 $0
Q1 2021 Jun 17, 2021	BUY	$132.81 - $182.18 $5,445 - $7,469	41 New	41 $7,000
Q1 2019 Sep 07, 2021	SELL	$35.52 - $62.62 $25,325 - $44,648	-713 Closed	0 $0
Q3 2018 Sep 07, 2021	BUY	$44.22 - $75.47 $31,528 - $53,810	713 New	713 $40,000
Q2 2018 Sep 07, 2021	SELL	$72.38 - $92.5 $25,839 - $33,022	-357 Closed	0 $0
Q1 2018 Sep 07, 2021	SELL	$69.46 - $88.57 $24,797 - $31,619	-357 Reduced 50.0%	357 $30,000
Q4 2017 Sep 07, 2021	BUY	$65.94 - $93.31 $47,081 - $66,623	714 New	714 $49,000
Q3 2017 Sep 07, 2021	SELL	$80.87 - $91.08 $54,829 - $61,752	-678 Closed	0 $0
Q2 2017 Sep 07, 2021	BUY	N/A	678	678 $50,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.